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LETTER TO THE EDITOR
The Effect of Ondansetron in Prevention of  
Postoperative Shivering after General Anesthesia  
in Gynecological Surgery 
 
 
Dear Editor, 
Shivering happens frequently in 5 to 60% of surgical 
operations.1 Though it occurs as a result of tempera-
ture reduction, it may occur in patients with a post-
operative normal body temperature.2 Shivering may 
be dangerous due to increasing effect of medicines, 
extension of recovery period, increased oxygen con-
sumption or hemostatic dysfunction especially in pa-
tients with a low cardiac reserve.3  
Several medications have been suggested for pre-
vention and treatment. According to regulator effect of 
intra-hypothalamic serotonin (5-ydroxytryptamine), its 
agonists (ondansetron) are reported to have the same 
effect.4 Opposed to meperidine, ondansetron may re-
duce post-operative nausea and vomiting (PONV).5 
A medication to reduce both PONV and shivering 
will be very valuable.6 This study evaluated preven-
tive effect of ondansetron and meperidine on post-
operative shivering compared to a control group. 
We did this study in Alavi University Hospital of 
Ardabil (IRAN) in 2008. The protocol was approved 
by ethical committee of this university. All patients 
were in ASA physiologic class I or II. Patients were 
randomly selected to receive either 4 mg ondansetron, 
0.4 mg/kg meperidine or 2 ml normal saline (the pla-
cebo) 2 minutes before inducting anesthesia.  
We induced anesthesia by 1µg/kg fentanyl, 5 
mg/kg thiopental and 1 mg/kg succinylcholine con-
tinued by 0.8-1% isoflurane along with the inspiration 
mixed of 50% oxygen and 50% N2O after intubation. 
Room temperature was set at 20-22°C. 
We measured core body and skin temperature 
through tympanic membrane and forehead accord-
ingly. Patients were observed for shivering (chills for 
at least 15 seconds), nausea or vomiting during re-
covery by an anesthesiologist blinded to the medica-
tion. Patients received appropriate care by meperidine 
for shivering and metoclopramide for nausea or vom-
iting when necessary. 
Data were statistically analyzed using SPSS soft-
ware (version 15, Chicago, IL, USA). All data were 
expressed as the mean±SD. A repeated-measure 
ANOVA was used for comparing core body tempera-
ture, skin temperature, systolic and diastolic blood 
pressure and heart rate in several stages (basic, post-
induction of anesthesia, end of surgery and in recov-
ery room) in each group and Chi-Square test wase 
used for comparing the prevalence of shivering, nau-
sea and vomiting in each group. A p-value less than 
0.05 was considered significant. 
There was no significant difference in age (p=0.49), 
operation duration (p=0.34), core body temperature 
(p=0.76) and skin temperature (p=0.79) between the 
groups. Core body temperature decline in control 
group was more in patients receiving ondansetron or 
meperidine (p=0.001), but no significant difference 
was observed between ondansetron and meperidine 
groups (p=0.09). There was no difference among three 
groups in the skin temperature decrease (p=0.27). 
Systolic and diastolic blood pressure was de-
creased in all of patients during the surgery and back 
to basic value in recovery. Heart rate increased after 
induction of anesthesia and decreased slightly during 
the operation and recovery. No significant difference 
[Systolic blood pressure (p=0.66), diastolic blood 
pressure (p=0.42) and heart rate (p=0.81)] was no-
ticed between three groups (p>0.05). 
Shivering occurred significantly lower in patients re-
ceiving ondansetron or meperidine compared whit con-
trol group (p value=0.003). Results are shown in Table1.  
The current study reports valuable preventive effects 
on shivering for ondansetron and meperidine compared 
to controls compatible with some previous reports. Kel-
saka reported a reduction in occurrence of shivering af-
ter a spinal anesthesia from 36% (in controls) to 8% by 
either ondansetron or meperidine.4 Piper reported failure 
of 12.5 mg dolansetron to decrease this rate which may 
be due to its inadequate dosage.1 While Powel reported 
shivering to occur in 57% of patients receiving saline 
compared to a rate of 33% followed by 4 mg ondanse-
tron (15%) followed by 8 mg ondansetron.7 They high-
lighted the effect of ondansetron to interfere thermo-
regulation by a central mechanism. 
Although meperidine has the minority effect on 
cardiovascular system with the dosage used for treat-
ing shivering (0.3-0.4 mg/kg), it may extensively de-
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press respiration especially if used during the sur-
gery.8 Results of this study demonstrated the safety of 
using ondansetron as well as its efficacy. 
In conclusion using ondansetron instead of 
meperidine is suggested because of its ability to re-
duce shivering from 50 to 13.3% in addition to lower 
side effects especially in patients with homodynamic 
instability. 
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Table1: Results of post-operative observation in three groups. 
 Control group (%) Ondansetron (%) Meperidine (%) P value 
Shivering  15 (50.0) 4 (13.3) 6 (20.0) 0.003 
Nausea  3 (10.0) 3 (10.0) 3 (10.0) 1.00 
Vomiting  2 (6.7) 0 1 (3.3) 0.30 
 
